The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

MaxCyte will host a conference call today, March 11, 2025, at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call are required to register online. A live and archived ...

(DX) software and technology for the commercial real estate industry, has announced the launch of elumo, a dynamic bookings and access solution that redefines the meeting room ...

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Daxor Corporation Conference ...

Fiscal 2024 was once again marked by major challenges and many economic uncertainties. Nevertheless, we have consistently advanced Henkel over the past year and reached or even exceeded important ...

Rhumbline Advisers increased its stake in ChromaDex Co. (NASDAQ:CDXC – Free Report) by 36.0% in the 4th quarter, according to ...

QIAGEN N.V.’s QGEN fourth-quarter performance was driven by solid potential in molecular diagnostics. The company continues to progress with its test menu expansion, building a solid foundation to ...

The outlet analyzed Zelenskyy’s efforts to restore relations with Washington, as the White House increases pressure on Kyiv ...

Antarctic Exchange (AX) has officially launched its mainnet, and is offering unique AX points activity as reward to early ...

PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...